What's New

8604

Nomura Holdings

Nomura Investment Forum 2022

Group CEO Kentaro Okuda
9229

SUNWELS Co.,Ltd.

FY March 2023, Second Quarter Financial Highlights

President and Representative Director Ryotatsu Nawashiro
8630

Sompo Holdings, Inc.

Progress of Mid Term Management Plan

Group CEO Kengo SAKURADA
8766

Tokio Marine Holdings, Inc.

Tokio Marine Group Business Strategy

President and Group CEO Satoru Komiya
8252

Marui Group., Ltd.

Overview of Performance in Six Months Ended September 30, 2022

Managing Executive Officer, CFO Hirotsugu Kato
7013

IHI Corporation

Financial Results for Second Quarter FY2022 (IFRS) (for the year ending March 31,2023)

President and CEO Hiroshi Ide
4523

Eisai Co., Ltd.

Q2 FY2022 (Fiscal Year Ending March 31, 2023) Financial Results Presentation

Representative Corporate Officer and CEO Haruo Naito
8604

Nomura Holdings, Inc.

Second Quarter Operating Results for Fiscal Year Ending March 2023

CFO Takumi Kitamura
8604

Nomura Holdings, Inc.

Nomura sustainability day 2022

4523

Eisai Co., Ltd.

Eisai Media/Investor Conference

Representative Corporate Officer and CEO Haruo Naito
4523

Eisai Co., Ltd.

Q1 FY2022 (Fiscal Year Ending March 31, 2023) Financial Results Presentation

Tatsuyuki Yasuno Senior Vice President Chief Financial Officer Chief IR Officer
4503

Astellas Pharma Inc.

Astellas Earnings Call -Q1/FY2022 Financial Results -

Chief Financial Officer (CFO) Minoru Kikuoka
8766

Tokio Marine Holdings, Inc.

Tokio Marine Insights 「Power to overcome a challenge」

Tokio Marine Kiln Group Chief Executive Officer Brad Irick
8630

Sompo Holdings, Inc.

Progress of Mid-Term Management Plan

Kengo SAKURADA Group CEO
8766

Tokio Marine Holdings, Inc.

Tokio Marine Group Business Strategy

President and Group CEO Satoru Komiya
8252

Marui Group., Ltd.

Financial Results Briefing for the Fiscal Year Ended March 31, 2022

President and Representative Director, Representative Executive Officer, CEO Hiroshi Aoi
8604

Nomura Holdings, Inc.

Investor Day

Group CEO
Kentaro Okuda
4523

Eisai Co., Ltd.

FY2021 (Fiscal Year Ended March 31, 2022) Financial Results Presentation

Representative Corporate Officer and CEO Haruo Naito
4503

Astellas Pharma Inc.

FY2021 financial Results ended March 31, 2022

President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
8766

Tokio Marine Holdings, Inc.

D&I at Tokio Marine Group

Mika Nabeshima, Group Chief Diversity & Inclusion Officer (CDIO), Tokio Marine Holdings
4503

Astellas Pharma Inc.

R&D Meeting -Initiatives for Gene Therapy-

President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
8630

Sompo Holdings, Inc.

Overview of Overseas Insurance Business

CEO of Overseas Insurance and Reinsurance Business James Shea
4503

Astellas Pharma Inc.

Sustainability Meeting

Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
4204

SEKISUI CHEMICAL CO., LTD.

Presentation of Financial Results for the 3Q of FY2021

Director, Senior Managing Executive Officer,
Head of Business Strategy Department Futoshi Kamiwaki
4503

Astellas Pharma Inc.

Astellas Earnings Call -Financial Results for the Q3 of FY2021-

Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
4503

Astellas Pharma Inc.

R&D meeting -New research organization structure -

Representative Director, Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
8766

Tokio Marine Holdings, Inc.

Tokio Marine Group Business Strategy

President and Group CEO Satoru Komiya
8630

Sompo Holdings, Inc.

Progress of Mid-Term Management Plan

Group CEO Kengo Sakurada
8252

Marui Group., Ltd.

Overview of Performance in Six Months Ended September 30,2021

President and Representative Director, Representative Executive Officer, CEO Hiroshi Aoi
4204

SEKISUI CHEMICAL CO., LTD.

Presentation of Financial Results and Progress under Management Plan for the 2Q of FY2021

President Keita Kato
4503

Astellas Pharma Inc.

Astellas Earnings Call -Financial Results for the Q2 of FY2021-

Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
4204

SEKISUI CHEMICAL CO., LTD.

Presentation of Financial Results for the 1Q of FY2021

Director, Senior Managing Executive Officer, Head of Business Strategy Dept. Futoshi Kamiwaki
8630

Sompo Holdings, Inc.

New Mid-Term Management Plan (Domestic Life / Nursing Care & Seniors Business)

Yasuhiro Oba CEO of Domestic Life Insurance Business
8252

Marui Group., Ltd.

MARUI IR DAY

Managing Executive Officer, President and Representative Director, Epos Card Co., Ltd. Yoshionori Saito
4503

Astellas Pharma Inc.

CSP2021(CSP: Corporate Strategic Plan)

Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
8252

Marui Group., Ltd.

2021年3月期決算説明会

代表取締役社長 青井 浩
4503

Astellas Pharma Inc.

Rx+ Day

Executive Vice President, Chief Strategy Officer and Chief Financial Officer
Naoki Okamura
8252

Marui Group., Ltd.

2020年3月期第2四半期決算説明会

代表取締役社長 青井 浩
4536

Santen Pharmaceutical Co., Ltd.

Q2 FY2020 Results

President & Chief Executive Officer Shigeo Taniuchi
8252

Marui Group., Ltd.

MARUI IR DAY 中期経営計画進捗説明会

上席執行役員㈱丸井 取締役社長
青木 正久
8252

Marui Group., Ltd.

Financial Results Briefing for the Fiscal Year Ended March 31, 2020 and Future Outlook

President and Representative Director, MARUI GROUP CO., LTD. Hiroshi Aoi
4536

Santen Pharmaceutical Co., Ltd.

Financial Disclosure Meeting FY2019 Business Highlights FY2020 Forecast

President & Chief Executive Officer Shigeo Taniuchi
8252

Marui Group., Ltd.

MARUI IR DAY 2019. 12

Hiroshi Aoi President and Representative Director, MARUI GROUP CO., LTD.
8252

Marui Group.Ltd.

Six Months Ended September 30 , 2019 Financial Results and Future Developments

Hiroshi Aoi President and Representative Director, MARUI GROUP CO., LTD.
8252

MARUI GROUP CO., LTD.

MARUI IR DAY 2018

Hiroshi Aoi President and Representative Director, Representative Executive Officer

Precautions in use

Nomura IR assumes no responsibility for correctness, validity or any other nature of the contents on this server.
No act such as alteration, modification or addition to the contents is permitted.
Since the contents on this server are not intended to solicit investment, our company has no liability for any trouble related to investment made by any audience based on the contents of this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity or any other nature of information, including its format and details, obtained from any site linked from our site.